Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386526779> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4386526779 endingPage "29" @default.
- W4386526779 startingPage "24" @default.
- W4386526779 abstract "Oral complications from cancer treatments are among the adverse effects breast cancer survivors can face. Yet such complications are often overlooked in cancer survivorship care. Many breast cancer survivors are receiving adjuvant endocrine therapy, but there is limited understanding of potential oral complications from this therapy.This study aimed to compare aspects of oral health in female breast cancer survivors who were taking adjuvant endocrine therapy with those of survivors not taking such therapy.National Health and Nutrition Examination Survey data collected from January 2009 through March 2020 were used for the analysis. Female adults ages 20 years and older who had been diagnosed with breast cancer were included. Linear regression and χ 2 analyses were conducted to examine aspects of oral health, using IBM SPSS Complex Samples software, version 27.In our sample of 423 female breast cancer survivors, 7.1% were taking tamoxifen, 7.8% were taking anastrozole, 4.3% were taking letrozole, and 2.9% were taking exemestane. Compared with the survivors not taking such therapy, a greater proportion of those taking it had decayed teeth, gum disease/problems, and were recommended for imminent dental care after oral health examination by dentists. The survivors who were not taking adjuvant endocrine therapy had more coronal cavities.Data analysis showed that female breast cancer survivors taking adjuvant endocrine therapy appear more likely to have oral health issues than those not taking such therapy. Improved awareness of these issues is critical. Assessment and management guidelines to address these oral health issues are needed by health care providers." @default.
- W4386526779 created "2023-09-08" @default.
- W4386526779 creator A5015198735 @default.
- W4386526779 creator A5083411583 @default.
- W4386526779 date "2023-10-01" @default.
- W4386526779 modified "2023-10-16" @default.
- W4386526779 title "Oral Health Concerns of Female Breast Cancer Survivors on Adjuvant Endocrine Therapy" @default.
- W4386526779 cites W2131696941 @default.
- W4386526779 cites W2904800374 @default.
- W4386526779 cites W2904991649 @default.
- W4386526779 cites W2914674644 @default.
- W4386526779 cites W2939489290 @default.
- W4386526779 cites W2979928382 @default.
- W4386526779 cites W3094766929 @default.
- W4386526779 cites W3095152095 @default.
- W4386526779 cites W3153195366 @default.
- W4386526779 cites W3176922661 @default.
- W4386526779 cites W4206841660 @default.
- W4386526779 cites W4315754639 @default.
- W4386526779 cites W4376849581 @default.
- W4386526779 doi "https://doi.org/10.1097/01.naj.0000978924.32557.53" @default.
- W4386526779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37678330" @default.
- W4386526779 hasPublicationYear "2023" @default.
- W4386526779 type Work @default.
- W4386526779 citedByCount "0" @default.
- W4386526779 crossrefType "journal-article" @default.
- W4386526779 hasAuthorship W4386526779A5015198735 @default.
- W4386526779 hasAuthorship W4386526779A5083411583 @default.
- W4386526779 hasConcept C121608353 @default.
- W4386526779 hasConcept C126322002 @default.
- W4386526779 hasConcept C143998085 @default.
- W4386526779 hasConcept C2775860665 @default.
- W4386526779 hasConcept C2776215463 @default.
- W4386526779 hasConcept C2777176818 @default.
- W4386526779 hasConcept C2777982462 @default.
- W4386526779 hasConcept C29456083 @default.
- W4386526779 hasConcept C509974204 @default.
- W4386526779 hasConcept C530470458 @default.
- W4386526779 hasConcept C71924100 @default.
- W4386526779 hasConceptScore W4386526779C121608353 @default.
- W4386526779 hasConceptScore W4386526779C126322002 @default.
- W4386526779 hasConceptScore W4386526779C143998085 @default.
- W4386526779 hasConceptScore W4386526779C2775860665 @default.
- W4386526779 hasConceptScore W4386526779C2776215463 @default.
- W4386526779 hasConceptScore W4386526779C2777176818 @default.
- W4386526779 hasConceptScore W4386526779C2777982462 @default.
- W4386526779 hasConceptScore W4386526779C29456083 @default.
- W4386526779 hasConceptScore W4386526779C509974204 @default.
- W4386526779 hasConceptScore W4386526779C530470458 @default.
- W4386526779 hasConceptScore W4386526779C71924100 @default.
- W4386526779 hasIssue "10" @default.
- W4386526779 hasLocation W43865267791 @default.
- W4386526779 hasLocation W43865267792 @default.
- W4386526779 hasOpenAccess W4386526779 @default.
- W4386526779 hasPrimaryLocation W43865267791 @default.
- W4386526779 hasRelatedWork W1996045572 @default.
- W4386526779 hasRelatedWork W2003583183 @default.
- W4386526779 hasRelatedWork W2039236423 @default.
- W4386526779 hasRelatedWork W2090744251 @default.
- W4386526779 hasRelatedWork W2106580915 @default.
- W4386526779 hasRelatedWork W2123746076 @default.
- W4386526779 hasRelatedWork W2134586533 @default.
- W4386526779 hasRelatedWork W2148104482 @default.
- W4386526779 hasRelatedWork W2167166423 @default.
- W4386526779 hasRelatedWork W4253288370 @default.
- W4386526779 hasVolume "123" @default.
- W4386526779 isParatext "false" @default.
- W4386526779 isRetracted "false" @default.
- W4386526779 workType "article" @default.